Lü Jin
Impact in
- Urology top 10%
- Reproductive Medicine top 10%
- Ovarian function and disorders
Papers in
-
- Epigenetics and DNA Methylation 4
- Renal and related cancers 4
- Surgery 14
- Co-authors
- Boxin Xue (6 shared papers)Xiao Min (1 shared paper)Qing Yu (1 shared paper)Mingwei Li (1 shared paper)Wenfei Zhang (1 shared paper)Guangcheng Dai (5 shared papers)Ding Zhang (1 shared paper)Zheyu Zhang (1 shared paper)
- Journals
- Cancer Research (4 papers)Scientific Reports (2 papers)PLoS ONE (2 papers)Oncotarget (2 papers)Cell Death Discovery (2 papers)
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Lü Jin
58 papers receiving 657 citations
Peers
Comparison fields: 5 of 112
- Urology 33
- Reproductive Medicine 38
- Cancer Research 67
- Obstetrics and Gynecology 29
- Genetics 34
Countries citing papers authored by Lü Jin
This map shows the geographic impact of Lü Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lü Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lü Jin more than expected).
Fields of papers citing papers by Lü Jin
This network shows the impact of papers produced by Lü Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lü Jin. The network helps show where Lü Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Lü Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 83 | |
| 2 | 2017 | 72 | |
| 3 | 2020 | 46 | |
| 4 | 2016 | 31 | |
| 5 | 2015 | 29 | |
| 6 | 2018 | 27 | |
| 7 | 2019 | 27 | |
| 8 | 2020 | 24 | |
| 9 | 2016 | 19 | |
| 10 | 2021 | 17 | |
| 11 | 2023 | 16 | |
| 12 | 2019 | 15 | |
| 13 | 2021 | 15 | |
| 14 | 2018 | 14 | |
| 15 | 2015 | 14 | |
| 16 | 2018 | 14 | |
| 17 | 2023 | 12 | |
| 18 | 2022 | 12 | |
| 19 | 2022 | 12 | |
| 20 | Lycorine suppresses cell growth and invasion via down-regulation of NEDD4 ligase in bladder cancer. | 2022 | 11 |
About Lü Jin
Lü Jin is a scholar working on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 61 papers that have together received 671 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Epigenetics and DNA Methylation (4 papers), Renal and related cancers (4 papers), Urological Disorders and Treatments (4 papers), Kidney Stones and Urolithiasis Treatments (4 papers), Urologic and reproductive health conditions (3 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Urology (33 citations), Reproductive Medicine (38 citations), Cancer Research (67 citations), Obstetrics and Gynecology (29 citations) and Genetics (34 citations). Lü Jin has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Boxin Xue, Xiao Min, Qing Yu, Mingwei Li, Wenfei Zhang, Guangcheng Dai, Ding Zhang, Zheyu Zhang, Yuxiang Shao and Fangjie Wo. Their work appears in journals such as Cancer Research, Scientific Reports, PLoS ONE, Oncotarget and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.